InCarda Therapeutics, Inc. — Form D/A
InCarda Therapeutics, Inc. of NEWARK, CA, a company, filed a Form D amendment with the SEC on 2014-12-19. The offering totals $12.9M, of which $567K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-12-19
- Form: D/A
- Accession: 0001552622-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.9M
- Amount sold: $567K
- Remaining: $12.3M
- Investors: 13
- Date of first sale: 2013-09-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-202665
Issuer
- Name: InCarda Therapeutics, Inc.
- CIK: 0001552622
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 39899 BALENTINE DRIVE, SUITE 185, NEWARK, CA, 94560
- Phone: 408-219-2576
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Grace S Colon | Director | San Francisco, CA |
| John S Patton | Director | Durham, NC |
| Carlos A Schuler | Director | San Francisco, CA |
| Grace S Colon | Executive Officer | San Francisco, CA |
| John S Patton | Executive Officer | Durham, NC |
| Carlos A Schuler | Executive Officer | San Francisco, CA |
| Alan Colowick | Director | Belmont, CA |
| Andrew ElBardissi | Director | St. Louis Park, MN |
| Isaac Cheng | Director | Portland, ME |
| Johan Christenson | Director | NEWARK, CA |
| Grace Colon | Director | NEWARK, CA |
| Grace Colon | Executive Officer | NEWARK, CA |
| Dan Welch | Director | NEWARK, CA |
| Bischofberger Norbert | Director | Newark, CA |
| Rangachari Narasimhan | Director | Brisbane, CA |
| Rangachari Narasimhan | Executive Officer | Brisbane, CA |
| McCarthy Reenie | Director | Brisbane, CA |
| Miller Samantha | Executive Officer | Brisbane, CA |
Other filings by this issuer (5)
More